Market Overview

Sterne Agee Reiterates Neutral Rating on Aeropostale

Share:
Related ARO
Mid-Afternoon Market Update: Dow Falls 100 Points; Sarepta Therapeutics Shares Drop Following Release of FDA Briefing Documents on Eteplirsen
Aeropostale's Stock Plunges Following Bloomberg Report Company Is Preparing To Declare Bankruptcy
Bids come in for bankrupt Aeropostale (Seeking Alpha)

In a report published Monday, Sterne Agee Group reiterated its Neutral rating on Aeropostale (NYSE: ARO).

Sterne Agee noted, “While we expect Q3 results at ARO to be in line, our checks of weekend sales suggest a less robust start to holiday than the peer group and we believe Q4 guidance may fall below consensus views as a result. Our Q4 estimate is $0.47 compared to the $0.54 consensus. Last year ARO earned $0.44.”

Aeropostale closed on Friday at $14.45.

Latest Ratings for ARO

DateFirmActionFromTo
Aug 2015Wolfe ResearchInitiates Coverage onPeer Perform
Jul 2015UBSDowngradesNeutralSell
May 2015FBR CapitalMaintainsMarket Perform

View More Analyst Ratings for ARO
View the Latest Analyst Ratings

Posted-In: Sterne Agee GroupAnalyst Color Reiteration Analyst Ratings

 

Related Articles (ARO)

View Comments and Join the Discussion!